0
Controversies in Internal Medicine |

The Importance of Screening for Hemochromatosis

Suja Dubois, MD; Kris V. Kowdley, MD
Arch Intern Med. 2003;163(20):2424-2426. doi:10.1001/archinte.163.20.2424.
Text Size: A A A
Published online

Extract

HEREDITARY HEMOCHROMATOSIS, commonly described as human leukocyte antigen–linked or HFE-associated hemochromatosis, is an inherited disorder of iron metabolism leading to excessive absorption of iron from the gastrointestinal tract.1 Patients with hemochromatosis may develop progressive iron loading in many parenchymal organs, resulting in cirrhosis complicated by liver failure or hepatocellular carcinoma, diabetes, arthropathy, and cardiac disease. Patients with cirrhosis associated with HH have a significantly increased risk of premature mortality. By contrast, patients diagnosed prior to the development of cirrhosis have a normal life expectancy when compared with age- and sex-matched controls.2 Therefore, population screening for HH has been advocated with the goal of identifying patients in the precirrhotic stage of the disease, particularly because noninvasive, sensitive, and specific screening tests are available and because iron depletion therapy is safe and can lead to improved outcomes. Furthermore, the identification of the HFEgene has made possible confirmation of the diagnosis of HH using DNA-based testing for the homozygous C282Y mutation.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Place holder to copy figure label and caption

Suja Dubois, MD

Graphic Jump Location
Place holder to copy figure label and caption

Kris V. Kowdley, MD

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 7

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();